Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B/glycogen synthase kinase-3β/β-catenin signaling.

Chen J, Chan AW, To KF, Chen W, Zhang Z, Ren J, Song C, Cheung YS, Lai PB, Cheng SH, Ng MH, Huang A, Ko BC.

Hepatology. 2013 Jun;57(6):2287-98. doi: 10.1002/hep.26278. Epub 2013 Apr 26.

PMID:
23348706
2.

CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling.

Zhou SL, Zhou ZJ, Hu ZQ, Li X, Huang XW, Wang Z, Fan J, Dai Z, Zhou J.

Cancer Lett. 2015 Mar 28;358(2):124-35. doi: 10.1016/j.canlet.2014.11.044. Epub 2014 Nov 24.

PMID:
25462858
3.

Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transition.

Chung KY, Cheng IK, Ching AK, Chu JH, Lai PB, Wong N.

Hepatology. 2011 Jul;54(1):307-18. doi: 10.1002/hep.24372.

PMID:
21520196
4.

As an independent prognostic factor, FAT10 promotes hepatitis B virus-related hepatocellular carcinoma progression via Akt/GSK3β pathway.

Liu L, Dong Z, Liang J, Cao C, Sun J, Ding Y, Wu D.

Oncogene. 2014 Feb 13;33(7):909-20. doi: 10.1038/onc.2013.236. Epub 2013 Jul 1.

PMID:
23812429
5.

Enhanced myeloid differentiation factor 88 promotes tumor metastasis via induction of epithelial-mesenchymal transition in human hepatocellular carcinoma.

Jia RJ, Cao L, Zhang L, Jing W, Chen R, Zhu MH, Guo SW, Wu GB, Fan XY, Wang H, Zhang YY, Zhou XY, Zhao J, Guo YJ.

Cell Death Dis. 2014 Mar 6;5:e1103. doi: 10.1038/cddis.2014.71.

6.

Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.

Du R, Wu S, Lv X, Fang H, Wu S, Kang J.

J Exp Clin Cancer Res. 2014 Dec 14;33:105. doi: 10.1186/s13046-014-0105-6.

7.

Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling.

Zhang Q, Bai X, Chen W, Ma T, Hu Q, Liang C, Xie S, Chen C, Hu L, Xu S, Liang T.

Carcinogenesis. 2013 May;34(5):962-73. doi: 10.1093/carcin/bgt027. Epub 2013 Jan 27.

8.

Downregulation of LncRNAH19 and MiR-675 promotes migration and invasion of human hepatocellular carcinoma cells through AKT/GSK-3β/Cdc25A signaling pathway.

Lv J, Ma L, Chen XL, Huang XH, Wang Q.

J Huazhong Univ Sci Technolog Med Sci. 2014 Jun;34(3):363-9. doi: 10.1007/s11596-014-1284-2. Epub 2014 Jun 18.

PMID:
24939300
9.

Mechanism of hepatitis C virus (HCV)-induced osteopontin and its role in epithelial to mesenchymal transition of hepatocytes.

Iqbal J, McRae S, Banaudha K, Mai T, Waris G.

J Biol Chem. 2013 Dec 27;288(52):36994-7009. doi: 10.1074/jbc.M113.492314. Epub 2013 Nov 15.

10.

Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways.

Ogunwobi OO, Liu C.

Clin Exp Metastasis. 2011 Dec;28(8):721-31. doi: 10.1007/s10585-011-9404-x. Epub 2011 Jul 10.

11.

Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.

Hou KZ, Fu ZQ, Gong H.

World J Gastroenterol. 2015 Jan 14;21(2):475-83. doi: 10.3748/wjg.v21.i2.475.

12.

Protocadherin 9 inhibits epithelial-mesenchymal transition and cell migration through activating GSK-3β in hepatocellular carcinoma.

Zhu P, Lv J, Yang Z, Guo L, Zhang L, Li M, Han W, Chen X, Zhuang H, Lu F.

Biochem Biophys Res Commun. 2014 Sep 26;452(3):567-74. doi: 10.1016/j.bbrc.2014.08.101. Epub 2014 Aug 27.

13.

MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.

Bao L, Yan Y, Xu C, Ji W, Shen S, Xu G, Zeng Y, Sun B, Qian H, Chen L, Wu M, Su C, Chen J.

Cancer Lett. 2013 Sep 1;337(2):226-36. doi: 10.1016/j.canlet.2013.05.007. Epub 2013 May 14.

PMID:
23684551
14.

Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways.

Yan D, Avtanski D, Saxena NK, Sharma D.

J Biol Chem. 2012 Mar 9;287(11):8598-612. doi: 10.1074/jbc.M111.322800. Epub 2012 Jan 23.

15.

Cyclin G1-mediated epithelial-mesenchymal transition via phosphoinositide 3-kinase/Akt signaling facilitates liver cancer progression.

Wen W, Ding J, Sun W, Fu J, Chen Y, Wu K, Ning B, Han T, Huang L, Chen C, Xie D, Li Z, Feng G, Wu M, Xie W, Wang H.

Hepatology. 2012 Jun;55(6):1787-98. doi: 10.1002/hep.25596. Epub 2012 Apr 25.

PMID:
22271581
16.
17.

BTB/POZ domain-containing protein 7: epithelial-mesenchymal transition promoter and prognostic biomarker of hepatocellular carcinoma.

Tao YM, Huang JL, Zeng S, Zhang S, Fan XG, Wang ZM, Yang HX, Yuan XH, Wang P, Wu F, Luo J, Zeng DY, Shen H.

Hepatology. 2013 Jun;57(6):2326-37. doi: 10.1002/hep.26268.

PMID:
23325674
18.

Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.

Zhu K, Dai Z, Pan Q, Wang Z, Yang GH, Yu L, Ding ZB, Shi GM, Ke AW, Yang XR, Tao ZH, Zhao YM, Qin Y, Zeng HY, Tang ZY, Fan J, Zhou J.

Clin Cancer Res. 2011 Dec 1;17(23):7294-302. doi: 10.1158/1078-0432.CCR-11-1327. Epub 2011 Oct 5.

19.

Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.

Zhou SL, Dai Z, Zhou ZJ, Wang XY, Yang GH, Wang Z, Huang XW, Fan J, Zhou J.

Hepatology. 2012 Dec;56(6):2242-54. doi: 10.1002/hep.25907.

PMID:
22711685
20.

CUL4B activates Wnt/β-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists.

Yuan J, Han B, Hu H, Qian Y, Liu Z, Wei Z, Liang X, Jiang B, Shao C, Gong Y.

J Pathol. 2015 Apr;235(5):784-95. doi: 10.1002/path.4492. Epub 2015 Jan 23.

PMID:
25430888
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk